Industry Leaders Grapple With Trump’s Most Favored Nation Pricing Plan

 
• By Jessica Merrill

At the Bank of America health care conference, pharma leaders speculated on the impact of Trump’s most favored nation pricing executive order on US and European markets.

Industry executives said aligning US and European prices would be difficult. (Shutterstock)

More from Pricing Debate

More from Market Access